Mednax Inc (MD) 72.46 $MD Mednax Shares Up 34.2% Since

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mednax Inc (MD) 72.46 $MD

Mednax Shares Up 34.2% Since SmarTrend's Buy Recommendation (MD)
Comtex SmarTrend(R) - Fri Mar 20, 11:23AM CDT
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 5 months, Mednax has returned 34.25% as of today's recent price of $72.99.
MD: 72.46 (+0.32)

Mednax initiates second $200M accelerated share repurchase program
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:19PM CDT

MD: 72.46 (+0.32)

Mednax Has Returned 35.3% Since SmarTrend Recommendation (MD)
Comtex SmarTrend(R) - Fri Mar 13, 9:50AM CDT
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 5 months, Mednax has returned 35.31% as of today's recent price of $73.57.
MD: 72.46 (+0.32)

MEDNAX Commences Second $200 Million Accelerated Share Repurchase Program
Business Wire - Thu Mar 12, 6:00AM CDT
MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatal, anesthesia, maternal-fetal, pediatric cardiology, and other pediatric physician services, today announced the commencement of a second $200 million accelerated share repurchase (ASR) program with JPMorgan Chase Bank, N.A. This program follows the Company's first ASR that commenced in December, 2014.
MD: 72.46 (+0.32)

Insider Trading Alert - OMC, MD And EDE Traded By Insiders
at The Street - Mon Mar 02, 11:45AM CST
Stocks with insider trader activity include OMC, MD and EDE
OMC: 78.31 (+0.08), EDE: 25.54 (+0.55), MD: 72.46 (+0.32)

Seeking Daruma: Zen And The Art Of Small Cap Investing
Matthew Finston - at Seeking Alpha - Fri Feb 20, 10:07AM CST

CSGP: 196.78 (-0.88), PRGO: 172.87 (+2.50), XYL: 35.99 (+0.45), FRAN: 16.13 (+0.08), TTI: 5.91 (+0.27), LL: 28.51 (-0.84), HLS: 45.30 (+0.35), GOOG: 560.36 (+2.37), PVH: 102.44 (+0.81), STNG: 9.05 (+0.04), ROG: 83.28 (+0.29), TRAK: 38.84 (-0.25), WCG: 93.72 (+0.61), MD: 72.46 (+0.32), SPN: 21.19 (+0.82), MU: 28.68 (+0.63), WLL: 39.03 (-1.04), EFII: 42.06 (+0.77), DGI: 34.75 (+0.04), PBI: 23.96 (+0.71), UHS: 118.76 (+0.03), CDNS: 18.66 (+0.06), BECN: 30.43 (+1.08), NXPI: 108.03 (+2.71), LYV: 25.50 (-0.01), PODD: 33.95 (-0.43), WEX: 107.22 (+3.31), ASGN: 38.80 (+0.13), AIG: 55.94 (+0.29), CTCT: 38.97 (+0.69), OXM: 58.38 (-0.08), STKL: 11.01 (+0.50), AWI: 57.53 (+1.24), MFRM: 67.72 (+3.69), BDC: 92.13 (+1.46), QEP: 20.78 (+0.38), BC: 51.25 (+0.15), SHLM: 44.79 (+0.45), MNRO: 66.92 (+0.74), VRA: 15.84 (-0.01), GOOGL: 564.95 (+1.28), AVY: 53.49 (+0.49), OC: 42.43 (+2.71), WAB: 96.57 (+1.39), CRZO: 47.86 (+1.37), NATI: 32.83 (-0.02), DBD: 34.59 (+0.39), RATE: 11.73 (+0.13), ALGN: 57.18 (-1.14), FBHS: 46.16 (+1.08), WDC: 100.44 (+1.14), DIN: 106.25 (+0.23), ACXM: 19.59 (unch), TCBI: 49.54 (+0.91), PLL: 103.61 (-0.47), FUL: 43.81 (+0.49), PCRX: 97.64 (-0.08), BABA: 85.20 (-0.54)

Sector Rankings Stay Neutral With Few Bullish Catalysts On Horizon
Scott Martindale - at Seeking Alpha - Wed Feb 18, 12:49AM CST
Stocks are hitting new highs across the board, even though earnings reports have been somewhat disappointing. Actually, to be more precise, Q4 results have been pretty good, but it is forward guidance that has been cautious and/or cloudy as sales...
IYK: 105.91 (+1.16), ACHC: 72.77 (+1.17), IYJ: 109.99 (+0.71), BX: 38.69 (unch), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), AMP: 136.17 (+2.83), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IHF: 134.41 (+0.34), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), MRVL: 15.72 (-0.08), IDU: 113.91 (+1.13), FONE: 40.83 (+0.46), MD: 72.46 (+0.32), AVGO: 133.29 (+1.25), IYW: 107.91 (+0.62)

Mednax Up 30.9% Since SmarTrend Uptrend Call (MD)
Comtex SmarTrend(R) - Thu Feb 12, 10:02AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 4 months, Mednax has returned 30.88% as of today's recent price of $71.16.
MD: 72.46 (+0.32)

Mednax Up 26.6% Since SmarTrend Uptrend Call (MD)
Comtex SmarTrend(R) - Thu Feb 05, 9:15AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 4 months, Mednax has returned 26.60% as of today's recent price of $68.83.
MD: 72.46 (+0.32)

'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head
at The Street - Thu Feb 05, 5:00AM CST
Cramer says take the money and run on NPS Pharmaceuticals, stay away from VMware and he missed the boat on OvaScience.
AMBA: 72.39 (+3.14), BX: 38.69 (unch), VMW: 82.82 (+1.05), OVAS: 46.97 (+1.98), NBR: 13.15 (+0.36), ALK: 68.68 (+0.33), HPQ: 33.28 (+0.44), SLB: 82.37 (+1.36), LUV: 46.36 (+0.01), HAIN: 64.44 (+0.88), SSYS: 58.89 (+0.51), NPSP: 45.97 (+0.01), PPC: 26.84 (-0.10), FLT: 152.16 (+0.65), MD: 72.46 (+0.32)

Blackstone Is An Excellent Holding - Cramer's Lightning Round (2/4/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Thu Feb 05, 4:21AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 4. Bullish Calls: Alaska Air (NYSE: ALK ): " I like Alaska Air and I like Southwest Airlines (NYSE: LUV )." OvaScience (NASDAQ:...
AMBA: 72.39 (+3.14), BX: 38.69 (unch), OVAS: 46.97 (+1.98), VMW: 82.82 (+1.05), NBR: 13.15 (+0.36), ALK: 68.68 (+0.33), HPQ: 33.28 (+0.44), SLB: 82.37 (+1.36), LUV: 46.36 (+0.01), SSYS: 58.89 (+0.51), PPC: 26.84 (-0.10), NPSP: 45.97 (+0.01), FLT: 152.16 (+0.65), MD: 72.46 (+0.32)

Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead
at The Street - Wed Feb 04, 7:26PM CST
Many of the stocks hit hard Wednesday will rise again soon enough, Cramer says.
KMI: 42.12 (+0.59), MMM: 166.49 (+0.83), BX: 38.69 (unch), VMW: 82.82 (+1.05), OVAS: 46.97 (+1.98), NKE: 101.98 (+3.66), FRPT: 18.31 (-0.16), NBR: 13.15 (+0.36), WYNN: 129.98 (-0.13), RL: 133.18 (+0.54), UPS: 100.25 (+0.34), SLB: 82.37 (+1.36), LUV: 46.36 (+0.01), WHR: 197.95 (+3.81), JNJ: 102.40 (+0.71), BC: 51.25 (+0.15), CMG: 686.65 (+5.98), SSYS: 58.89 (+0.51), PPC: 26.84 (-0.10), NPSP: 45.97 (+0.01), DG: 75.78 (+0.87), CAT: 81.19 (+1.10), MD: 72.46 (+0.32), AAPL: 125.90 (-1.60), REGN: 488.87 (+2.85), WFM: 53.97 (+0.35), AMBA: 72.39 (+3.14), NSC: 110.43 (+0.12), MCK: 229.94 (+4.19), NUE: 47.14 (+1.04), HAL: 42.82 (+1.27), DIS: 108.43 (+1.06), COP: 63.84 (+1.08), BMY: 67.76 (-0.56), ALK: 68.68 (+0.33), HPQ: 33.28 (+0.44), CELG: 128.50 (+3.17), HAIN: 64.44 (+0.88), TTWO: 25.68 (-0.04), GILD: 102.29 (+0.85), MCD: 97.05 (+1.07), FLT: 152.16 (+0.65), PG: 84.74 (+1.36)

Mednax: Investment Thesis Intact, Discount Is Gone
Investing Doc - at Seeking Alpha - Tue Feb 03, 7:32AM CST

MD: 72.46 (+0.32)

Economy And ObamaCare Lift Walk-In Surgery At AmSurg
at Investor's Business Daily - Mon Feb 02, 1:52PM CST
Most medical stocks are considered defensive plays, which means that they're a good place to put your money during downturns. The reason is simple: People need medical care regardless of the economy, so medical stocks won't suffer when the economy is...
AMSG: 64.02 (-0.19), AFAM: 38.81 (-0.25), SCAI: 35.04 (+0.02), HLS: 45.30 (+0.35), MD: 72.46 (+0.32)

Insider Trading Alert - MD, OKSB And UPI Traded By Insiders
at The Street - Mon Feb 02, 9:56AM CST
Stocks with insider trader activity include MD, OKSB and UPI
OKSB: 17.17 (+0.63), UPI: 1.10 (-0.03), MD: 72.46 (+0.32)

MEDNAX Announces Acquisition of Anesthesiology Practice in Michigan
Business Wire - Fri Jan 30, 6:00AM CST
MEDNAX, Inc. (NYSE: MD), today announced the acquisition of MEMAC Associates, P.C., a private physician group practice based in Warren, Mich., and its related entity, Synergy Anesthesia, PLLC. At closing, 10 anesthesiologists, as well as 18 part-time anesthetists, became part of MEDNAX's American Anesthesiology division, and will serve as one integrated practice.
MD: 72.46 (+0.32)

Team Health Holdings: A Well-Run Company With Strong Growth Prospects
Real Estater - at Seeking Alpha - Fri Jan 30, 12:24AM CST

AMSG: 64.02 (-0.19), EVHC: 38.60 (+0.42), TMH: 59.25 (+0.66), MD: 72.46 (+0.32)

SmarTrend Watching for Potential Pullback in Shares of Mednax After 6.68% Gain
Comtex SmarTrend(R) - Thu Jan 29, 4:39PM CST
Mednax (NYSE:MD) traded in a range yesterday that spanned from a low of $64.80 to a high of $69.20. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $65.49 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MD: 72.46 (+0.32)

MEDNAX (MD) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 2:30PM CST

MD: 72.46 (+0.32)

Barbarian At The Gate: Mednax (MD)
at The Street - Thu Jan 29, 9:44AM CST
Trade-Ideas LLC identified Mednax (MD) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MD: 72.46 (+0.32)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 120

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 106

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 138

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 244

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 95

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

Under Armour and UNLESS: A New Era in Sustainable Sportswear

Updated Category News Views 185

Under Armour and UNLESS Unveil Groundbreaking Sportswear Innovative Launch at Milan Design Week Under Armour, Inc. and UNLESS, Inc. are set to revolutionize the sportswear industry by introducing a remarkable regenerative sportswear collection during Milan Design Week. This innovative project is a significant milestone representing their first collaboration, focusing on...

Continue Reading
Primech Holdings Expands Reach in North America, Targets Growth

Updated Category News Views 111

Primech Holdings Expands Presence in North America Primech Holdings Limited (NASDAQ: PMEC) has marked a significant milestone by opening its United States office in Edwardsville, Illinois. This expansion into North America is driven by the increasing demand for advanced, AI-driven cleaning solutions among institutional clients. Strategic Location for Growth Illinois was...

Continue Reading
Quantum Computing Inc. Secures $500 Million Through Private Placement

Updated Category News Views 296

Quantum Computing Inc. Strengthens Financial Backbone Quantum Computing Inc. (NASDAQ: QUBT), a pioneering company in the realm of integrated photonics and quantum optics technologies, has made headlines with its significant financing move. Recently, QCi announced that it has successfully arranged a private placement of common stock, amassing $500 million. This capital...

Continue Reading
Glaukos Takes Major Step with Epioxa™ FDA Application

Updated Category News Views 80

Glaukos Takes Major Step with Epioxa™ FDA Application Glaukos Corporation (NYSE: GKOS), a distinguished ophthalmic pharmaceutical and medical technology enterprise, has made significant strides by filing a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Epioxa™, its state-of-the-art keratoconus therapy. This innovative treatment...

Continue Reading
Freshpet's Upcoming Q1 2025 Results and Company Growth Insights

Updated Category News Views 222

Freshpet to Share First Quarter Results for 2025 Freshpet, Inc. is set to disclose its financial results for the first quarter concluding on March 31, 2025. The announcement is scheduled for the morning of May 5, 2025, just before the market opens. As a public company operating under Nasdaq: FRPT, Freshpet has garnered significant attention in the pet food industry....

Continue Reading